-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Analysis of FACS Platform Features and Advantages
Author:
InnoModels
Release time:
2024-05-11
With the rapid development of life sciences, Flow Cytometry (FACS for short) has become an important technical means for modern biological research. As a leader in this field, the FACS platform of InnoModels Biotechnology has won the favor of researchers with its unique advantages and features. In this paper, we will analyze the features of FACS platform of InnoModels Biotechnology in detail.
1、Highly flexible multi-parameter analysis capability
The core advantage of the FACS platform is its highly flexible multi-parameter analysis capability. With the advanced multi-channel laser and fluorescent label detection system, the platform is able to accurately detect multiple cellular markers at the same time to achieve comprehensive cellular characterization. Whether for immunophenotyping, cell cycle research or stem cell research, the platform can provide accurate and reliable data to help researchers gain a deeper understanding of cell function and properties.
2. Wide range of applications
Another major feature of the FACS platform is its wide range of applications. The platform is not only suitable for basic scientific research, but also widely used in drug development, immunotherapy and clinical diagnosis. By providing researchers with a wide selection of instruments and reagent kits, the platform can meet the needs of different research directions and help researchers make breakthroughs in various fields.

3. Personalized Solutions
InnoModels Biotechnology understands that every research project has its own unique needs, so they focus on in-depth cooperation with customers to provide personalized solutions. Through in-depth understanding of the specific needs of researchers, the company is able to customize appropriate experimental solutions for them, ensuring the accuracy and reliability of experimental results.
4、Advanced Technical Support
As a leading biotechnology company in the industry, InnoModels Biotechnology provides strong technical support for the FACS platform. The company's professional team has a wealth of experience and technical knowledge, and is able to provide researchers with a full range of training and technical guidance. In addition, the company also ensures that the FACS platform always maintains its leading position in the industry through continuous technological innovation and product upgrades.
5. Reliable Data Quality
In bioscience research, data quality is crucial. The FACS platform of InnoModels Biotechnology ensures the accuracy and reliability of data with its excellent performance and stability. The advanced instruments and algorithms adopted by the platform can effectively reduce noise and errors and improve the signal-to-noise ratio of data. In addition, the company has established a strict data quality control system to ensure the accuracy and reproducibility of each experimental result.
In summary, with its highly flexible multi-parameter analysis capability, wide range of application areas, personalized solutions, advanced technical support and reliable data quality, the InnoModels Biotechnology FACS platform has become an important tool for modern biological research. The platform not only provides researchers with precise and efficient experimental means, but also opens up new research fields and possibilities for them. In the future, with the continuous development of biotechnology, the FACS platform of InnoModels Biotechnology will continue to exert its unique advantages and bring more breakthroughs and innovations to the field of scientific research.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd